These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6447725)
21. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Nazarov V; Hilbert D; Wolff L Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249 [TBL] [Abstract][Full Text] [Related]
22. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422 [TBL] [Abstract][Full Text] [Related]
23. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants. Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575 [No Abstract] [Full Text] [Related]
24. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia. Finklestein JZ; Byfield J; Tittle K; Imagawa DT Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619 [No Abstract] [Full Text] [Related]
25. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells. Todd RF; Stulting RD; Berke G Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536 [No Abstract] [Full Text] [Related]
26. Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response. De Landazuri MO; Herberman RB J Natl Cancer Inst; 1972 Jul; 49(1):147-54. PubMed ID: 5037432 [No Abstract] [Full Text] [Related]
27. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells. Caulfield MJ; Cerny J J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291 [No Abstract] [Full Text] [Related]
28. Protection by immune spleen cells against challenge with Moloney sarcoma virus. Effect of stage of donor response. Pollack S; Nelson K Transplantation; 1973 May; 15(5):510-3. PubMed ID: 4710486 [No Abstract] [Full Text] [Related]
29. An immunochemotherapeutic system for the treatment of a transplanted Moloney virus-induced lymphoma in mice. Glynn JP; Halpern BL; Fefer A Cancer Res; 1969 Mar; 29(3):515-20. PubMed ID: 4180092 [No Abstract] [Full Text] [Related]
30. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor. Wiltrout RH; Frost P J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255 [No Abstract] [Full Text] [Related]
31. Immune response to weakly immunogenic virally induced tumors. IV. Dissociated recognition of H-2 and tumor-associated antigens. Devens B; Naor D; Kedar E Transplantation; 1979 Nov; 28(5):389-95. PubMed ID: 160637 [No Abstract] [Full Text] [Related]
32. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas. Pepersack L; Lee JC; McEwan R; Ihle JN J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293 [No Abstract] [Full Text] [Related]
33. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes. Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392 [No Abstract] [Full Text] [Related]
34. Effects of cholera toxin on the lymphoid system. III. In vivo generation of cytotoxic lymphocytes. Tsuru S; Nomoto K; Oka M; Zinnaka Y J Clin Lab Immunol; 1983 Apr; 10(4):209-14. PubMed ID: 6602889 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of murine humoral immune responses by substances derived from trypanosomes. Albright JW; Albright JF J Immunol; 1981 Jan; 126(1):300-3. PubMed ID: 6450237 [TBL] [Abstract][Full Text] [Related]
36. Requirement for direct cellular contact for immunosuppression by a murine virus-induced lymphoma (FBL-3). Cimprich RS; Specter S; Friedman H J Immunol; 1978 May; 120(5):1473-9. PubMed ID: 659857 [No Abstract] [Full Text] [Related]
38. Analysis of the cytotoxic T cell response to H-Y in CBA/H mice. Brenan M; Müllbacher A J Immunol; 1981 Aug; 127(2):681-5. PubMed ID: 6454725 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens. Lee JC; Horak I; Ihle JN J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice. Ahituv A; Naor D; Sharon R; Tarcic N; Klein BY Cancer Immunol Immunother; 1982; 14(1):16-26. PubMed ID: 6186365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]